SFM
CHRS icon

Sphera Funds Management’s Coherus Oncology CHRS Stock Holding History

Sphera Funds Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-75,600
Closed -$1.03M – 93
2019
Q1 		$1.03M Buy
+75,600
New +$1.01M 0.09% 93
2018
Q2 		– Sell
-270,000
Closed -$2.98M – 110
2018
Q1 		$2.98M Buy
+270,000
New +$2.95M 0.45% 63

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Sphera Funds Management's CHRS Position: Q2 2019 in Review

Sphera Funds Management sold out of Coherus Oncology (CHRS) in Q2 2019, closing a stake of 75,600 shares — an estimated $1.03M sold.

Sphera Funds Management first reported a position in CHRS in Q1 2018 and held it in 2 quarters. The position peaked at $2.98M in Q1 2018. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2019.

  • Sphera Funds Management reported no remaining Coherus Oncology position as of Q2 2019 after selling out during the quarter.
  • Sphera Funds Management sold 75,600 Coherus Oncology shares in Q2 2019, an estimated $1.03M.
  • Sphera Funds Management first reported a position in Coherus Oncology in Q1 2018 and held it in 2 quarters.
  • Sphera Funds Management's Coherus Oncology position peaked at $2.98M in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.